318 related articles for article (PubMed ID: 10426803)
1. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
Green A; Shilkaitis A; Christov K
Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
[TBL] [Abstract][Full Text] [Related]
2. Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell death.
Shilkaitis A; Green A; Steele V; Lubet R; Kelloff G; Christov K
Carcinogenesis; 2000 Feb; 21(2):227-33. PubMed ID: 10657962
[TBL] [Abstract][Full Text] [Related]
3. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
Moon RC; Pritchard JF; Mehta RG; Nomides CT; Thomas CF; Dinger NM
Carcinogenesis; 1989 Sep; 10(9):1645-9. PubMed ID: 2527636
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention.
Cope MB; Steele VE; Lubet RA; Eto I; Juliana MM; Hill DL; Grubbs CJ
Oncol Rep; 2004 Feb; 11(2):465-9. PubMed ID: 14719085
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
[TBL] [Abstract][Full Text] [Related]
6. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.
RodrÃguez-Burford C; Lubet RA; Eto I; Juliana MM; Kelloff GJ; Grubbs CJ; Steele VE
Carcinogenesis; 1999 Jan; 20(1):71-6. PubMed ID: 9934852
[TBL] [Abstract][Full Text] [Related]
7. Retinoids as chemopreventive agents for breast cancer.
Moon RC; Mehta RG; Detrisac CJ
Cancer Detect Prev; 1992; 16(1):73-9. PubMed ID: 1551141
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
[TBL] [Abstract][Full Text] [Related]
9. Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology.
RodrÃguez-Burford C; Steele VE; Anderson AS; Stockard CR; Weiss HL; Eto I; Johanning GL; Grizzle WE; Grubbs CJ
Nutr Cancer; 2002; 43(1):67-75. PubMed ID: 12467137
[TBL] [Abstract][Full Text] [Related]
10. Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea.
Thompson HJ; McGinley JN; Rothhammer K; Singh M
Carcinogenesis; 1995 Oct; 16(10):2407-11. PubMed ID: 7586143
[TBL] [Abstract][Full Text] [Related]
11. Hormone dependent and independent mammary tumor development form N-methyl-N-nitrosourea-treated rat mammary epithelial cell xenografts in the nude mouse: multiple pathways and H-ras activation.
Hwang SI; Guzman RC; Swanson SM; Nandi S
Cancer Lett; 1996 Mar; 101(1):123-34. PubMed ID: 8625275
[TBL] [Abstract][Full Text] [Related]
12. N-(4-hydroxyphenyl)all-trans-retinamide (4-HPR) high dose effect on DMBA-induced hamster oral cancer: a histomorphometric evaluation.
Lajolo C; Giuliani M; Sgambato A; Majorano E; Lucchese A; Capodiferro S; Favia G
Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1133-40. PubMed ID: 18657950
[TBL] [Abstract][Full Text] [Related]
13. Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea.
Thompson HJ; Singh M; McGinley J
J Mammary Gland Biol Neoplasia; 2000 Apr; 5(2):201-10. PubMed ID: 11149573
[TBL] [Abstract][Full Text] [Related]
14. Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis.
Crist KA; Wang Y; Lubet RA; Steele VE; Kelloff GJ; You M
J Cell Biochem Suppl; 1997; 27():92-9. PubMed ID: 9591198
[TBL] [Abstract][Full Text] [Related]
15. Influence of chemopreventive agents on estradiol metabolism and mammary preneoplasia in the C3H mouse.
Osborne MP; Telang NT; Kaur S; Bradlow HL
Steroids; 1990 Mar; 55(3):114-9. PubMed ID: 2139751
[TBL] [Abstract][Full Text] [Related]
16. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
17. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
18. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats.
McCormick DL; Rao KV; Dooley L; Steele VE; Lubet RA; Kelloff GJ; Bosland MC
Cancer Res; 1998 Aug; 58(15):3282-8. PubMed ID: 9699656
[TBL] [Abstract][Full Text] [Related]
19. Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions.
Korkola JE; Archer MC
Carcinogenesis; 1999 Feb; 20(2):221-7. PubMed ID: 10069457
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
